CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+4.75%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$5.32B
AUM Growth
+$155M
(+3%)
Cap. Flow
-$127M
Cap. Flow
% of AUM
-2.38%
Top 10 Holdings %
Top 10 Hldgs %
16.3%
Holding
745
New
50
Increased
312
Reduced
249
Closed
35
Top Buys
| 1 |
Kellanova
K
|
$30.1M |
| 2 |
Colgate-Palmolive
CL
|
$20M |
| 3 |
Corning
GLW
|
$19.4M |
| 4 |
Merck
MRK
|
$18.9M |
| 5 |
SPLS
Staples Inc
SPLS
|
$18M |
Top Sells
| 1 |
PepsiCo
PEP
|
$40.6M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$37.8M |
| 3 |
Meta Platforms (Facebook)
META
|
$23.6M |
| 4 |
Oracle
ORCL
|
$22.4M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$21.2M |
Sector Composition
| 1 | Healthcare | 25.58% |
| 2 | Technology | 13.64% |
| 3 | Financials | 13.2% |
| 4 | Consumer Discretionary | 9.51% |
| 5 | Communication Services | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CALA
301
DELISTED
Calithera Biosciences, Inc
CALA
| $3.98M | 0.07% |
13,405
-2,855
| -18% | -$848K |
|
302
Karyopharm Therapeutics
KPTI
$57.2M
| $3.96M | 0.07% |
29,200
+17,733
| +155% | +$2.41M |
|
303
Labcorp
LH
$23.2B
| $3.95M | 0.07% |
29,854
+493
| +2% | +$65.3K |
|
|
FNSR
304
DELISTED
Finisar Corp
FNSR
| $3.95M | 0.07% |
+152,091
| New | +$3.95M |
|
305
Idexx Laboratories
IDXX
$51.4B
| $3.91M | 0.07% |
+24,211
| New | +$3.91M |
|
306
Ford
F
$46.7B
| $3.9M | 0.07% |
348,886
+31,715
| +10% | +$355K |
|
307
Tractor Supply
TSCO
$32.1B
| $3.9M | 0.07% |
+359,800
| New | +$3.9M |
|
308
Kraft Heinz
KHC
$32.3B
| $3.9M | 0.07% |
45,542
+1,325
| +3% | +$113K |
|
|
NBL
309
DELISTED
Noble Energy, Inc.
NBL
| $3.9M | 0.07% |
137,639
+16,999
| +14% | +$481K |
|
|
ARRY
310
DELISTED
Array Biopharma Inc
ARRY
| $3.89M | 0.07% |
465,000
+10,000
| +2% | +$83.7K |
|
311
Marsh & McLennan
MMC
$100B
| $3.89M | 0.07% |
49,881
+933
| +2% | +$72.7K |
|
312
eBay
EBAY
$42.3B
| $3.88M | 0.07% |
111,015
+599
| +0.5% | +$20.9K |
|
313
Marathon Petroleum
MPC
$54.8B
| $3.85M | 0.07% |
73,546
-168,856
| -70% | -$8.84M |
|
314
General Mills
GIS
$27B
| $3.82M | 0.07% |
69,006
-11,930
| -15% | -$661K |
|
315
ICICI Bank
IBN
$113B
| $3.82M | 0.07% |
425,700
+280,500
| +193% | +$2.52M |
|
316
Bank of New York Mellon
BK
$73.1B
| $3.8M | 0.07% |
74,452
+4,859
| +7% | +$248K |
|
|
EGRX
317
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.79M | 0.07% |
48,000
| – | – |
|
|
DDC
318
DELISTED
Dominion Diamond Corporation
DDC
| $3.77M | 0.07% |
300,000
| – | – |
|
319
Ultragenyx Pharmaceutical
RARE
$3.07B
| $3.73M | 0.07% |
60,000
-9,000
| -13% | -$559K |
|
320
Northrop Grumman
NOC
$83.2B
| $3.71M | 0.07% |
14,468
-170
| -1% | -$43.6K |
|
321
Edwards Lifesciences
EW
$47.5B
| $3.71M | 0.07% |
94,194
-14,028
| -13% | -$553K |
|
|
RVNC
322
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.7M | 0.07% |
140,000
+18,000
| +15% | +$475K |
|
323
Scotiabank
BNS
$78.8B
| $3.61M | 0.07% |
60,094
-4,989
| -8% | -$300K |
|
324
Hologic
HOLX
$14.8B
| $3.61M | 0.07% |
79,542
-101,323
| -56% | -$4.6M |
|
325
EQT Corp
EQT
$32.2B
| $3.55M | 0.07% |
111,203
-11,808
| -10% | -$377K |
|